Closing Bell: Cardiol Therapeutics Inc down on Thursday (CRDL)

Today in trading, shares of Cardiol Therapeutics Inc opened at $2.99 and closed at $2.90. prices ranged from $2.81 to $2.99.

Shares dipped -2.68% from the previous day's close of $2.98.

During the day across North America, the TSX Composite closed -1.68% at 22723.21, the S&P 500 closed 1.58% at 5522.30, the Dow Jones Industrial Average closed 0.24% at 40842.79 and the Nasdaq Composite closed 2.64% at 17599.40.

Cardiol Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker CRDL.

Trading volume was 57,008 on 185 total trades, while having an average volume of 81,736 over 5 days.

The TSX overall saw 907 price advancers against 4,327 declines and 72 unchanged.

During the prior 52 weeks, CRDL.TO has traded as high as $4.26 (June 12,2024) and low as $0.91 (October 23,2023). Moreover, in the last 12 months, Cardiol Therapeutics Inc's shares have risen 101.39 percent, while this year, they have risen 163.64%.

Following today's trading, Cardiol Therapeutics Inc has a market capitalization of $206.79 million on a float of 69,391 shares outstanding. Its annual EPS is $-0.47.

Cardiol Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Oakville, CAN.

Currently, Cardiol Therapeutics Inc has an average recommendation of "Strong Sell" based on 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..